glp 1 receptor agonists are contraindicated in Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs Benefits and Risks of GLP-1

doi: 10.1111/dom.12651 68 HeinlaKVasarESedmanTVolkeV

Statements Data availability statement The original contributions presented in the study are included in the article/ Supplementary Materials , further inquiries can be directed to the corresponding author/s

L., Hong P

In recent years, GLP-1 medications like Ozempic have progressed from a specialised diabetes treatment into a more widespread weight loss tool used by a wide range of people globally

At a dosage of 1.8 mg/day, liraglutide has been proven to significantly lower ALT levels in patients with elevated baseline values, with a dose-dependent effect

Spichak, S